In the News

Connect with us

Stay Informed.
Get the latest news and updates on MSK’s cancer care and research breakthroughs sent straight to your inbox with our e-newsletters.
Newsletter Sign Up
501 News Items found
MSK and Hartford leadership holding certificate
Announcement
MSK Cancer Alliance Grants Hartford HealthCare Cancer Institute Certified Member Status

The certification comes after a year in which hundreds of experts worked together to assess standards of care at Hartford HealthCare Cancer Institute.
Papillary renal cell carcinoma under the microscope
Finding
Study Suggests More People with Kidney Cancer Should Be Screened for Hereditary Cancer Genes

Researchers have found that more than 20% of people with a type of cancer called advanced non-clear cell renal cell carcinoma have disease that is driven by inherited cancer mutations.
Mom and daughter having conversation
Ask the Expert
10 Tips for Talking with Your Child about Cancer

Find tools for discussing a cancer diagnosis with your children.
DNA molecules wrapped around histones
Feature
The Future of Cancer Research: Five Reasons for Optimism

Discover some of the most exciting research that Memorial Sloan Kettering scientists are pursuing in the fight against cancer.
Joan Massagué
How Cancer Spreads: Four Emerging Insights About Metastasis

Sloan Kettering Institute Director Dr. Joan Massagué talks about our updated understanding of cancer metastasis.
Pictured: Joan Massagué
Cancer Biologist Joan Massagué Honored on Two Continents

Joan Massagué, Chair of the Cancer Biology and Genetics Program in the Sloan Kettering Institute, has been named the recipient of two prestigious awards.
Scientist Gabriela Chiosis in her lab
In the Lab
Experimental Drug Targets Misbehaving Proteins in Brain Cancer and Alzheimer’s Disease

Memorial Sloan Kettering researchers are studying how drugs that reverse malfunctioning proteins may treat disease.
Dr. Alicia Latham, Dr. Michael Walsh, Dr. Zsofia Stadler, and Megha Ranganathan
Feature
Inherited Cancer Risks: New Insights from MSK Presented at 2023 ASCO Meeting

MSK investigators are leading research focused on understanding how hereditary DNA mutations affect cancer development and therapy, and how to best treat people who carry these inherited risks in their genes.
MSK gastroenterologist Robin Mendelsohn seen smiling at desk.
How Does an At-Home Colorectal Cancer Screening Test Compare to a Colonoscopy? Answers From an Expert at Memorial Sloan Kettering Cancer Center

Learn about the difference methods of colorectal cancer screening, including the at-home Cologuard test, from an expert at Memorial Sloan Kettering Cancer Center.
Portrait of a live zebrafish with dark patterning around and above the eyes
In the Lab
Uncharted Waters: The Making of a New Cancer Drug

A team of scientists is combining sophisticated chemistry and experiments in zebrafish to develop a new cancer drug that shows early potential against melanoma and metastatic breast cancer.